Post-approval Surveillance on Safety and Clinical Utility of Garenoxacin Mesylate in Patients with Community Acquired Respiratory Tract Infections
Introduction: Respiratory Tract Infections (RTIs) have become increasingly difficult to treat owing to the increase in resistant Gram positive and Gram negative bacteria. Garenoxacin mesylate, a novel synthetic des-F(6)-quinolone has been approved in India in the year 2013 for treatment of bacterial...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2018-01-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/11062/31892_F(AnG)_PF1_(MS_EK_SL)_PFA(MJ_AnG)_PN(AP).pdf |